BPC-157 (10mg)
Technische Spezifikationen
| Reinheit (HPLC) | ≥99% (HPLC) |
| CAS-Nummer | 137525-51-0 |
| Form | White lyophilized powder |
| Lagerung | -20°C |
| Sequenz | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Molekulargewicht | 1,419.53 g/mol |
| Salzform | Acetate |
| Löslichkeit | Soluble in water, DMSO |
BPC-157 (10mg)
EUR-Listenpreis · HU, SK, CZ, PL
- Eurozone (EUR)106,67 EUR
- Ungarn (HU)106,67 EUR≈ 42 668 Ft
- Slowakei (SK)106,67 EUR
- Tschechien (CZ)106,67 EUR≈ 2 667 Kč
- Polen (PL)106,67 EUR≈ 453,35 zł
Gleicher EUR-Listenpreis für Lieferung nach Ungarn, Slowakei, Tschechien und Polen. Abrechnung in EUR.
HUF/CZK/PLN sind indikativ aus EUR umgerechnet; die Slowakei nutzt EUR. Kurse annähernd. Abrechnung in EUR.
BPC-157 10 mg — größeres Format des Pentadecapeptids BPC-157 für umfangreichere Forschungsprotokolle. Dieselben Mechanismen (VEGFR2, Angiogenese, Geweberegeneration) in der Präklinik zitiert. Nur RUO — ausschließlich für Laborforschung; nicht zum menschlichen Verzehr.
Ausschließlich für Laborforschung.
Nicht für den menschlichen Verzehr, tierärztliche oder diagnostische Zwecke.
From the Peptide Explorer
A 15-amino-acid gastric pentadecapeptide with remarkable stability in the GI tract. One of the most extensively studied peptides in regenerative research with over 100 publications spanning wound healing, angiogenesis, tendon repair, and cytoprotection.
Key Mechanisms
- ›VEGFR2 upregulation
- ›FAK-paxillin pathway activation
- ›ERK1/2 signaling
- ›NO system modulation
- ›Growth hormone receptor upregulation
Primary Research Areas
- ›Wound healing
- ›Tendon & ligament repair
- ›GI cytoprotection
- ›Angiogenesis
- ›Neuroprotection
Key Research Findings
- Accelerated tendon-to-bone healing in rat models (Chang et al., 2014)
- Promoted angiogenesis via VEGFR2 in endothelial cells (Hsieh et al., 2017)
- Demonstrated GI cytoprotective effects against NSAID damage (Sikiric et al., 2018)
Research Overview
A 15-amino-acid gastric pentadecapeptide with remarkable stability in the GI tract. One of the most extensively studied peptides in regenerative research with over 100 publications spanning wound healing, angiogenesis, tendon repair, and cytoprotection.
Origin: Derived from human gastric juice protein BPC
Mechanism of Action
- VEGFR2 upregulation
- FAK-paxillin pathway activation
- ERK1/2 signaling
- NO system modulation
- Growth hormone receptor upregulation
Primary Research Areas
- Wound healing
- Tendon & ligament repair
- GI cytoprotection
- Angiogenesis
- Neuroprotection
Key Published Findings
- Accelerated tendon-to-bone healing in rat models (Chang et al., 2014)
- Promoted angiogenesis via VEGFR2 in endothelial cells (Hsieh et al., 2017)
- Demonstrated GI cytoprotective effects against NSAID damage (Sikiric et al., 2018)
Research Protocol
Commonly studied routes: Subcutaneous, Oral. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
-20°C lyophilized, 2-8°C reconstituted (3-4 weeks)
Important Notice
BPC-157 (10mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Forschungsspezifikationen
Synthesized for strict analytical consistency. Verified via HPLC/MS.Qualitätsstandards ansehen →
Handhabung & Lagerung
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water, DMSO